The Irish government was not alerted by the European Commission of the decision to trigger Article 16 of the NI Protocol as part of its launch of the vaccine transparency mechanism, @rtenews understands
2/ Officials have spoken of their "shock" and "concern" at the move. The Taoiseach Micheal Martin has spoken by phone to @vonderleyen "more than once"
3/ Officials suspect the Commission's Brexit Task Force was not alerted to the move, or was alerted "late in the day". Maros Sefcovic, who chairs the Joint Committee implementing the NI Protocol has been in touch with Michael Gove, his opposite number, it's understood
Here's the European Commission's first reaction to the publication of the contract, as per spokesman @ericmamer
"There are a number of plants which are mentioned in the contract we have with AstraZeneca, some of which are located in the United Kingdom...
2/ "...and that it is foreseen that these plants will contribute to the efforts of AstraZeneca to deliver doses to the European Union.
"There is absolutely no question for us that this is what the contract specifies.
3/ "We are convinced that this applies to the fact when we signed the advanced purchase agreement, the vaccines of course did not yet exist. They were in the process of being developed.
.@SKyriakidesEU: In our contract it is not specified that any country, or the UK, has priority because it signed earlier. Our contract foresees a quarter by quarter schedule.
If this was the case [ie, because the UK signed earlier] AZ should have proposed a clause in the contract acknowledging that they would have prioritised deliveries to the UK, but here is no such clause
Commissioner says: the numbers shared with us on Fri [by AZ] did not correspond with what was in the advanced purchase agreement and to what we expected.
NEW: EU official says EU has contacted AstraZeneca to seek approval to publish vaccine contract
Official says the company has been "very, very" protective of the contract, so it is "surprising" that Pascal Soriot revealed elements of the contract in the interview with Die Welt and La Republicca
Emer Cooke, EMA: only thing EMA can do in terms of production capacity is to work with companies and MS to ensure new manufacturing sites become available as soon as possible
"We will do everything we can to facilitate production from a scientific and regulator perspective"
Cooke: (AstraZeneca) Studies done have a very small quantity of elderly populations. Our scientific committee is looking at the totality of the data to see what that data means in terms of the populations that are studied
NEW: the EU has challenged AstraZeneca to spell out where its has sent vaccines so far. Stella Kyriakides, EU health commissioner: "The new AstraZeneca vaccine schedule is not acceptable to the EU." Kyriakides says she wrote letter to AZ asking "important and serious" questions:
2/ Kyriakides: "The EU has prefinanced the development of the vaccine and its production and wants to see its return. The EU wants to know exactly which doses have been produced where by AstraZeneca so far, and if, or to whom, they have been delivered.
3/ "These questions were also discussed today in the Joint Steering Board of the Commission and the 27 member states with AstraZeneca. The answers of the company have not been satisfactory so far. That's why a second meeting is scheduled for tonight.